These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123. Binding and intracellular trafficking of lipoprotein lipase and triacylglycerol-rich lipoproteins by liver cells. Casaroli-Marano RP; García R; Vilella E; Olivecrona G; Reina M; Vilaró S J Lipid Res; 1998 Apr; 39(4):789-806. PubMed ID: 9555944 [TBL] [Abstract][Full Text] [Related]
124. Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages. Liu Y; Wang W; Zou Z; Hu Z; Fan Q; Xiong J Dig Dis Sci; 2019 May; 64(5):1226-1237. PubMed ID: 30535782 [TBL] [Abstract][Full Text] [Related]
126. Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact. Crouchet E; Baumert TF; Schuster C Expert Rev Proteomics; 2017 Jul; 14(7):593-606. PubMed ID: 28625086 [TBL] [Abstract][Full Text] [Related]
127. Binding of liver derived, low density hepatitis C virus to human hepatoma cells. Martin C; Nielsen SU; Ibrahim S; Bassendine MF; Toms GL J Med Virol; 2008 May; 80(5):816-23. PubMed ID: 18360895 [TBL] [Abstract][Full Text] [Related]
130. Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry. Benedicto I; Molina-Jiménez F; Moreno-Otero R; López-Cabrera M; Majano PL World J Gastroenterol; 2011 Jun; 17(22):2683-90. PubMed ID: 21734774 [TBL] [Abstract][Full Text] [Related]
131. Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric Andreo U; de Jong YP; Scull MA; Xiao JW; Vercauteren K; Quirk C; Mommersteeg MC; Bergaya S; Menon A; Fisher EA; Rice CM Cell Mol Gastroenterol Hepatol; 2017 Nov; 4(3):405-417. PubMed ID: 28936471 [TBL] [Abstract][Full Text] [Related]
132. Antipeptide antibodies reveal interrelationships of MBP 200 and MBP 235: unique apoB-specific receptors for triglyceride-rich lipoproteins on human monocyte-macrophages. Bradley WA; Brown ML; Ramprasad MP; Li R; Song R; Gianturco SH J Lipid Res; 1999 Apr; 40(4):744-52. PubMed ID: 10191299 [TBL] [Abstract][Full Text] [Related]
133. Roles of lipoprotein receptors in the entry of hepatitis C virus. Lyu J; Imachi H; Fukunaga K; Yoshimoto T; Zhang H; Murao K World J Hepatol; 2015 Oct; 7(24):2535-42. PubMed ID: 26527170 [TBL] [Abstract][Full Text] [Related]
134. The rate of hepatitis C virus infection initiation in vitro is directly related to particle density. Sabahi A; Marsh KA; Dahari H; Corcoran P; Lamora JM; Yu X; Garry RF; Uprichard SL Virology; 2010 Nov; 407(1):110-9. PubMed ID: 20800257 [TBL] [Abstract][Full Text] [Related]
136. Progress with hepatitis C. Griffiths P Rev Med Virol; 2006; 16(4):205-7. PubMed ID: 16823762 [No Abstract] [Full Text] [Related]
137. Myosin 9 and N-glycans jointly regulate human papillomavirus entry. Zhang Y; Liu W; He F; Liu YJ; Jiang H; Hao C; Wang W J Biol Chem; 2024 Feb; 300(2):105660. PubMed ID: 38242322 [TBL] [Abstract][Full Text] [Related]
138. [In vitro hepatitis C. Elimination of lipoproteins associated with cells: an important stage to obtain an efficient infection of human hepatocytes by the hepatitis C virus]. Favre D; Berthillon P; Trépo C Rev Med Suisse Romande; 2002 Apr; 122(4):205. PubMed ID: 12071140 [No Abstract] [Full Text] [Related]
139. SMAD About Hepatitis C Virus Cell Entry and Liver Disease. Colpitts CC; Baumert TF Gastroenterology; 2017 Jan; 152(1):21-23. PubMed ID: 27889572 [No Abstract] [Full Text] [Related]